6919.TW
6919.TW
TW0006919004
CALIWAY BIOPHARMACEUTICALS CO L
Loading chart...

Financials

Trends
* Timeframes marked with (Est.) are analyst estimates based on consensus data.
Details
Breakdown 2025 2024 Change %
Total Revenue 38.037.000 44.434.000
14.4%
Cost of Revenue 11.517.000 13.673.000
15.8%
Gross Profit 26.520.000 30.761.000
13.8%
733.744.000 747.905.000
1.9%
Operating Income -707.224.000 -717.144.000
1.4%
Pretax Income -351.918.000 -588.830.000
40.2%
Net Income Common Stockholders -351.918.000 -588.830.000
40.2%
-- --
--
-- --
--
ende